タイトル |
Prediction of remission in pharmacotherapy of untreated major depression: development and validation of multivariable prediction models
|
著者 |
Furukawa Toshi A.
Kato Tadashi
Shinagawa Yoshihiro
Miki Kazuhira
Fujita Hirokazu
Tsujino Naohisa
Kondo Masaki
Yamada Mitsuhiko
|
収録物名 |
PSYCHOLOGICAL MEDICINE
|
巻 | 49 |
号 | 14 |
開始ページ | 2405 |
終了ページ | 2413 |
収録物識別子 |
ISSN 0033-2917
EISSN 1469-8978
|
主題 |
Major depression; pharmacotherapy; prediction model; remission
|
言語 |
英語
|
資源タイプ | 学術雑誌論文 |
出版者 |
CAMBRIDGE UNIV PRESS
|
発行日 | 2019-10 |
アクセス権 | メタデータのみ |
関連情報 |
[DOI] 10.1017/S0033291718003331
[PMID] 30430961
|
備考 | The study was funded by the Ministry of Health, Labor and Welfare, Japan (H-22-Seishin-Ippan-008) from April 2010 through March 2012 to TAF (http://www.mhlw.go.jp/english/), and thereafter by the Japan Foundation for Neuroscience and Mental Health (JFNMH) to TAF (http://www.jfnm.or.jp/). The JFNMH received donations from Asahi Kasei, Eli Lilly, GSK, Janssen, MSD, Meiji, Mochida, Otsuka, Pfizer, Shionogi, Taisho, and Mitsubishi-Tanabe. The study is partly supported by Japan Agency for Medical Research and Development (18dk0307072) and the Ministry of Health, Labour and Welfare (H29-ICT-Ippan-010). The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. |